Anna Thomas, executive vice president, presented in a virtual panel, “Disrupting Rare Disease Patient Outcomes through Innovation,” for the American Medical Group Association (AMGA).
She joined healthcare leaders from Alnylam, Houston Methodist and Texas Neurology to discuss innovative solutions for improving care delivery and patient outcomes around rare disease.